BR9910905A - Vacinas de gnrh para suprimir comportamento reprodutivo em animais. - Google Patents

Vacinas de gnrh para suprimir comportamento reprodutivo em animais.

Info

Publication number
BR9910905A
BR9910905A BR9910905-0A BR9910905A BR9910905A BR 9910905 A BR9910905 A BR 9910905A BR 9910905 A BR9910905 A BR 9910905A BR 9910905 A BR9910905 A BR 9910905A
Authority
BR
Brazil
Prior art keywords
gnrh
animals
reproductive behavior
methods
suppress
Prior art date
Application number
BR9910905-0A
Other languages
English (en)
Inventor
Sarah C Robbins
Original Assignee
Metamorphix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metamorphix Inc filed Critical Metamorphix Inc
Publication of BR9910905A publication Critical patent/BR9910905A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

VACINAS DE GnRH PARA SUPRIMIR COMPORTAMENTO REPRODUTIVO EM ANIMAIS São relatados métodos para conseguir a supressão de comportamento reprodutivo e/ou da fertilidade num sujeito vertebrado. Os métodos utilizam composições as quais incluem imunógenos de GnRH, análogos de GnRH tais como agonistas e antagonistas de GnRH, e anticorpos de GnRH. Os métodos são úteis para a supressão prolongada de função testicular em machos e função ovariana em fêmeas.
BR9910905-0A 1998-06-04 1999-05-28 Vacinas de gnrh para suprimir comportamento reprodutivo em animais. BR9910905A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8802498P 1998-06-04 1998-06-04
US30668999A 1999-05-06 1999-05-06
PCT/CA1999/000493 WO1999062545A2 (en) 1998-06-04 1999-05-28 GnRH VACCINES FOR SUPPRESSING REPRODUCTIVE BEHAVIOUR IN ANIMALS

Publications (1)

Publication Number Publication Date
BR9910905A true BR9910905A (pt) 2001-02-13

Family

ID=26777682

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910905-0A BR9910905A (pt) 1998-06-04 1999-05-28 Vacinas de gnrh para suprimir comportamento reprodutivo em animais.

Country Status (6)

Country Link
EP (1) EP1098661A2 (pt)
JP (1) JP2002516875A (pt)
AU (1) AU771556B2 (pt)
BR (1) BR9910905A (pt)
NZ (1) NZ509137A (pt)
WO (1) WO1999062545A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012522522A (ja) * 2009-04-06 2012-09-27 ユニバーシティー オヴ サスカチュワン 志賀毒素産生大腸菌感染を処置及び予防するための方法並びに組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556555A (en) * 1985-01-25 1985-12-03 North Carolina State University Process for the immunological neutering of animals
WO1988005308A1 (en) * 1987-01-14 1988-07-28 Commonwealth Scientific And Industrial Research Or Anti reproductive hormone
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.
GB8921470D0 (en) * 1989-09-22 1989-11-08 Peptide Technology Ltd Vaccines
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras

Also Published As

Publication number Publication date
NZ509137A (en) 2004-01-30
AU4026199A (en) 1999-12-20
EP1098661A2 (en) 2001-05-16
JP2002516875A (ja) 2002-06-11
WO1999062545A2 (en) 1999-12-09
WO1999062545A3 (en) 2001-03-15
AU771556B2 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
MXPA02005602A (es) Compuestos de urea que tienen actividad antagonista para el receptor muscarinico.
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
DK0725782T3 (da) A1-adenosin-receptor-agonister og antiagonister
PT1274687E (pt) Derivados de 1,2,3,4-tetra-hidroisoquinolina
UY25794A1 (es) Procedimiento para la preparacion de compuestos derivados de adeninas, que son agonistas del receptor de la adenosina a2a
EA200101203A1 (ru) Производные пурина
DE59906975D1 (de) Wässrige reaktive spachtelmassen (i)
DE69532162D1 (de) Cannabinoid-rezeptor-antagonisten
BR9806296B1 (pt) compostos de ácido sulfìnico, mistura, composição e uso dos mesmos.
BRPI0110801B8 (pt) análogos antitumorais de et-743, composição farmacêutica compreendendo os mesmos e uso dos referidos análogos
TR200000782T2 (tr) Resorsinol türevleri.
ES2202855T3 (es) Uso de antagonistas 5ht3 para promover el lavado intestinal.
ATE309197T1 (de) Verfahren zur herstellung alkylierter salicylamide
NO20070294L (no) Gonadotropinfrigjorende hormon reseptor antagonister
GT199800042A (es) Nuevos derivados del acido hexanoico.
EA200300593A1 (ru) Соединения пиперазинилпиразинов в качестве агонистов или антагонистов серотонин 5-ht2 рецептора
PT1263752E (pt) Agonistas e antagonistas dos receptores do lpa e métodos de utilização
MX9710392A (es) Antagonistas de receptores de vitronectina, su preparacion asi como su empleo.
NZ326608A (en) Adenosine and xanthine derivative as a1 adenosine receptor agonists and antagonists
EA200400454A1 (ru) Мускариновые агонисты
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
SV2002000041A (es) Derivados de resorcinol ref. pc10529/82897/bb
IT1270612B (it) Derivati eterociclo-condensatori di morfinoidi
BR9910905A (pt) Vacinas de gnrh para suprimir comportamento reprodutivo em animais.
EA200100853A1 (ru) Резорциновая композиция

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: METAMORPHIX, INC. (US)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDO NA PETICAO NO 015309/RJ DE 22/03/2004.

B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.